An Open-label, Randomized, Single-dose Crossover Study to Evaluate the Pharmacokinetics, Safety and Tolerability of HCP1903 in Healthy Subjects
Latest Information Update: 18 Jul 2022
At a glance
- Drugs Ezetimibe/rosuvastatin (Primary) ; HGP 1909 (Primary) ; HGP 1910 (Primary)
- Indications Hypercholesterolaemia
- Focus Pharmacokinetics
- Sponsors Hanmi Pharmaceutical
- 12 Jul 2022 Status changed from active, no longer recruiting to completed.
- 22 Feb 2021 New trial record